Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Goldman Sachs Asset Management
AddedFeb 13, 2024
UpdatedJul 9, 2026
Goldman Sachs Asset Management

Goldman Sachs Asset Management

OperatingPart of Goldman Sachs

Goldman Sachs Asset Management provides investment solutions across traditional and alternative asset classes worldwide.

Location
New York City, NY, US
Founded
1991
Firm
Compare
Portfolio
Employees
News
Website

Investments

Rippling
Rippling
Series G

Total Raised

$1.6B

Rounds

8

Series G$450MMay 2025
Triveni Bio
Triveni Bio
Series C

Total Raised

$272M

Rounds

3

Series B$115MOctober 2024
Simetrik
Simetrik
Series B

Total Raised

$84.1M

Rounds

7

Series B$55MFebruary 2024
Bastille
Bastille

Total Raised

$83M

Rounds

5

Series C$44MJanuary 2024
Altus Power
Altus Power
Public

Total Raised

$2.4B

Rounds

10

Post Ipo Debt$100MJanuary 2024
Candex
Candex

Total Raised

$82M

Rounds

7

Series B$45MNovember 2023
Cogito
Cogito

Total Raised

$155.7M

Rounds

12

Series UnknownOctober 2023
Redwood Materials
Redwood Materials

Total Raised

$3.8B

Rounds

8

Series D$1BAugust 2023
Rapport Therapeutics
Rapport Therapeutics

Total Raised

$250M

Rounds

2

Series B$150MAugust 2023
Bowery Valuation
Bowery Valuation

Total Raised

$78M

Rounds

7

Series B$16.3MJuly 2023
Septerna
Septerna

Total Raised

$250M

Rounds

2

Series B$150MJuly 2023
Madhive
Madhive

Total Raised

$300M

Rounds

3

Private Equity$300MJune 2023
Impact Nano
Impact Nano

Total Raised

$32M

Rounds

1

Series Unknown$32MMay 2023
Torl Biotherapeutics
Torl Biotherapeutics

Total Raised

$158M

Rounds

1

Series B$158MApril 2023
Stripe
Stripe
Series A

Total Raised

$8.7B

Rounds

19

Series I$6.5BMarch 2023
Macro
Macro

Total Raised

$244.8M

Rounds

7

Private Equity$90MMarch 2023
Crux
Crux

Total Raised

$157.9M

Rounds

4

Series B$50MJanuary 2023
Netskope
Netskope
Public

Total Raised

$1.4B

Rounds

12

Convertible Note$401MJanuary 2023
Resilia
Resilia

Total Raised

$45.8M

Rounds

9

Series B$35MOctober 2022
Nested Therapeutics
Nested Therapeutics

Total Raised

$125M

Rounds

2

Series A$90MOctober 2022
Kate Farms
Kate Farms

Total Raised

$188M

Rounds

5

Series C$75MSeptember 2022
Pico
Pico
Public

Total Raised

$383.4M

Rounds

7

Private Equity$200MJuly 2022
SingleStore
SingleStore

Total Raised

$464.1M

Rounds

11

Series F$116MJuly 2022
Northvolt
Northvolt

Total Raised

$13.5B

Rounds

14

Late Stage Private$1BJuly 2022
Mayvenn
Mayvenn

Total Raised

$76M

Rounds

7

Series C$40MJune 2022